In GCT, the transmembrane epithelial adhesion molecule (EpCAM; CD326) constitutes a promising target for such an approach as it is broadly present on the surface of GCT of different origins irrespective of age, sex, site, and clinical tumor stage [17]. The gene discussed is EPCAM; the disease is granular cell tumor.